SCHEMBL30349474

SCHEMBL30349474

COc1ccc(CNc2cc(Nc3ccccc3OC)nc3c(C(=O)O)cnn23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 4/20 0.50
▸ STAT3 P40763 1/20 0.50
▸ MAPT P10636 6/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ POLB P06746 2/20 0.48
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ ASPH Q12797 1/20 0.46
▸ RIOX2 Q8IUF8 1/20 0.46
▸ KDM8 Q8N371 1/20 0.46
▸ ADORA3 P0DMS8 2/20 0.46
▸ ADORA2A P29274 2/20 0.46
▸ ADORA1 P30542 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CDK2 P24941 2/20 0.43
▸ CDK7 P50613 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30349340 0.91 ADORA3 (0.48) TYK2STAT3MAPTMEN1KMT2A
SCHEMBL30377589 0.85 POLB (0.51) MAPTMEN1KMT2APOLBKDM4E
SCHEMBL21887328 0.83 TYK2 (0.66) TYK2STAT3PDE4D
SCHEMBL30349442 0.83 TYK2 (0.77) TYK2STAT3PDE4D
SCHEMBL21811164 0.82 AKR1C3 (0.46) TYK2STAT3MAPTMEN1KMT2A
SCHEMBL30378401 0.82 TYK2 (0.53) TYK2STAT3MAPTPOLBKDM4E
SCHEMBL21887378 0.76 KCNH2 (0.44) TYK2STAT3MAPTMEN1KMT2A
SCHEMBL21887349 0.76 TYK2 (0.69) TYK2STAT3PDE4D
SCHEMBL21811202 0.75 TYK2 (0.60) TYK2STAT3MAPTMEN1KMT2A
SCHEMBL30349550 0.75 TYK2 (0.60) TYK2STAT3MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638915-B Pyrazolo [1,5-a ] pyrimidine-3-carboxamide derivatives for the treatment of psoriasis and systemic lupus erythematosus 伊莱利利公司 2023-04-07 — — CN disclosed
Send feedback